DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20180620

Delta bilirubin: a sensitive and predictive marker for acute rejection in liver transplant recipients

Deepa Gupta, Aditi Gupta, Arun Raizada

Abstract


Background: This study was aimed to investigate the diagnostic utility of delta bilirubin for acute rejection in liver transplant recipients.

Methods: The present study was conducted on 80 patients (56 men and 24 women) who were admitted for a major operation of liver transplantation at super-speciality hospital, Medanta-The Medicity, Gurgaon. The average age of the patients was 43±19 years. Data was analyzed as mean, standard deviation; student t test by using statistical package for social sciences (SPSS) software. Sensitivity, specificity, positive predictive value and negative predictive value were calculated in percentage.

Results: The result from the present study indicates that delta bilirubin had highest sensitivities of 93% whereas conjugated bilirubin has 43% while AST, ALT, GGT and ALKP had sensitivities of 61%, 81%, 80% and 31% respectively. There was a significant difference of delta bilirubin between rejection and non rejection transplant recipients.

Conclusions: Our findings supported that the serial measurement of delta bilirubin would be a reliable marker for recognizing early rejection in liver transplant recipients.


Keywords


Acute rejection, Delta bilirubin, Liver transplantation

Full Text:

PDF

References


National Institutes of Health. Consensus Development Conference Statement: Liver 2 transplantation,1983. Hepatology. 1984;4:1075-95.

Grand D, Wall W, Ghent C, Duff J, Kutt J, Stiller C, et al. liver transplantation: the problem of rejection. Transplant Proc. 1986;18:163-66.

Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123:1367-84.

Lauff JJ, Kasper ME, Wu TW, Ambroee RT. Isolation and preliminary characterization of a fraction of bilirubin in serum that is firmly bound to protein. Clin Chem. 1982;28:629-37.

Itoh S, Onishi S. Kinetic study of the photochemical changes of (ZZ)- bilirubin IX alpha bound to human serum albumin. Demonstration of (EZ)- bilirubin IX alpha as an intermediate in photochemical changes from (ZZ)- bilirubin IX alpha to (EZ)- cyclobilirubin IX. Biochem J. 1985;226-51.

Jansen PL, Elferink RPO. Hereditary hyperbilirubinemias: a molecular and mechanistic approach. Semin Liver Dis. 1988;8:168.

Wu TW, Levy GA, Samuel YL, Au JX, Grelg PD, Strasberg SM, et al. Delta bilirubin and conjugated bilirubin as a complementary marker of early rejection in liver transplant recipients. Clin Chem. 1990;36:1-9.

Clinical and Laboratory Standard Institute (CLSI). Procedures for the collection of diagnostic blood specimens by venipunture; Approved Standard 6th ed. Wayne, Pennsylvania, USA: CLSI; 2007.

Demetris AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25(3):658-63.

Haynes RB. How to read clinical journals: II. To learn about a diagnostic test. Can Med Assoc J. 1981;124:703-10.

Cole EH, Cardella CJ, Schulman J, Levy GA. Monocyte procoagulant activity and plasminogen activator. Transplantation. 1985;40:363-71.

Thuong GVH. Liver Biopsy in Liver Transplant Recipients. Semin Intervent Radiol. 2004;21(4):271-74.

Vierling JM, Fennell JRH. Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts. Hepatology. 1985;5:1076-82.

Cox CJ, Valdiserri RO, Zerbe TR, Genter JL. Ektaachem bilirubin fraction BC as predictor of liver transplant rejection. Transplantation. 1987;40:536-39.

Gautam A, Seligson H, Gordon ER, Seligson D, Boyer JL. Irreversible binding of conjugated bilirubin to albumin in cholestatic rats. J Clin Invest. 1984;73:873-77.

McDonagh AF, Palma LA, Lauff JJ, Wu TW. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest. 1984;74:763-70.

Wu TW, Au JX, Arbour F, Carey D, Yazawa N, Hashimoto N, et al. Serum biliprotein is a cytoprotective agent of potential physiologic significance. Hepatology. 1989;10(4):744.